Wolfgang Link
AuthID: R-001-068
51
TITLE: An integrated one-step system to extract, analyze and annotate all relevant information from image-based cell screening of chemical libraries Full Text
AUTHORS: Rabal, O; Link, W; G. Serelde, B; Bischoff, JR; Oyarzabal, J;
PUBLISHED: 2010, SOURCE: Molecular BioSystems, VOLUME: 6, ISSUE: 4
AUTHORS: Rabal, O; Link, W; G. Serelde, B; Bischoff, JR; Oyarzabal, J;
PUBLISHED: 2010, SOURCE: Molecular BioSystems, VOLUME: 6, ISSUE: 4
52
TITLE: Understanding FOXO, new views on old transcription factors
AUTHORS: Zanella, F; Link, W; Carnero, A;
PUBLISHED: 2010, SOURCE: Current Cancer Drug Targets, VOLUME: 10, ISSUE: 2
AUTHORS: Zanella, F; Link, W; Carnero, A;
PUBLISHED: 2010, SOURCE: Current Cancer Drug Targets, VOLUME: 10, ISSUE: 2
53
TITLE: High content screening: Seeing is believing Full Text
AUTHORS: Zanella, F; Lorens, JB; Link, W;
PUBLISHED: 2010, SOURCE: Trends in Biotechnology, VOLUME: 28, ISSUE: 5
AUTHORS: Zanella, F; Lorens, JB; Link, W;
PUBLISHED: 2010, SOURCE: Trends in Biotechnology, VOLUME: 28, ISSUE: 5
54
TITLE: Human TRIB2 is a repressor of FOXO that contributes to the malignant phenotype of melanoma cells Full Text
AUTHORS: Zanella, F; Renner, O; Garcia, B; Callejas, S; Dopazo, A; Peregrina, S; Carnero, A; Link, W;
PUBLISHED: 2010, SOURCE: Oncogene, VOLUME: 29, ISSUE: 20
AUTHORS: Zanella, F; Renner, O; Garcia, B; Callejas, S; Dopazo, A; Peregrina, S; Carnero, A; Link, W;
PUBLISHED: 2010, SOURCE: Oncogene, VOLUME: 29, ISSUE: 20
55
TITLE: Finding novel targets for anticancer therapy
AUTHORS: Link, W;
PUBLISHED: 2010, SOURCE: European Pharmaceutical Review, ISSUE: 2
AUTHORS: Link, W;
PUBLISHED: 2010, SOURCE: European Pharmaceutical Review, ISSUE: 2
INDEXED IN: 
Scopus
Scopus IN MY: 
ORCID
ORCID56
TITLE: Imaged-based high-throughput screening for anti-angiogenic drug discovery
AUTHORS: Evensen, L; Link, W; Lorens, JB;
PUBLISHED: 2010, SOURCE: Current Pharmaceutical Design, VOLUME: 16, ISSUE: 35
AUTHORS: Evensen, L; Link, W; Lorens, JB;
PUBLISHED: 2010, SOURCE: Current Pharmaceutical Design, VOLUME: 16, ISSUE: 35
57
TITLE: 183 Amino-alkyl substituted fused imidazoles: potent, selective and orally bioavailable inhibitors of PI3K Full Text
AUTHORS: Pastor, J; Martínez, S; R.M Álvarez; Varela, C; A.I Hernández; Rodríguez, S; Oyarzábal, J; Albarrán, M; Link, W; J.R Bischoff;
PUBLISHED: 2010, SOURCE: European Journal of Cancer Supplements, VOLUME: 8, ISSUE: 7
AUTHORS: Pastor, J; Martínez, S; R.M Álvarez; Varela, C; A.I Hernández; Rodríguez, S; Oyarzábal, J; Albarrán, M; Link, W; J.R Bischoff;
PUBLISHED: 2010, SOURCE: European Journal of Cancer Supplements, VOLUME: 8, ISSUE: 7
58
TITLE: Using multiplexed regulation of luciferase activity and GFP translocation to screen for FOXO modulators Full Text
AUTHORS: Zanella, F; Rosado, A; Garcia, B; Carnero, A; Link, W;
PUBLISHED: 2009, SOURCE: BMC Cell Biology, VOLUME: 10, ISSUE: 1
AUTHORS: Zanella, F; Rosado, A; Garcia, B; Carnero, A; Link, W;
PUBLISHED: 2009, SOURCE: BMC Cell Biology, VOLUME: 10, ISSUE: 1
59
TITLE: Chemical interrogation of FOXO3a nuclear translocation identifies potent and selective inhibitors of phosphoinositide 3-kinases
AUTHORS: Link, W; Oyarzabal, J; Serelde, BG; Albarran, MI; Rabal, O; Cebria, A; Alfonso, P; Fominaya, J; Renner, O; Peregrina, S; Soilan, D; Ceballos, PA; Hernandez, AI; Lorenzo, M; Pevarello, P; Granda, TG; Kurz, G; Carnero, A; Bischoff, JR;
PUBLISHED: 2009, SOURCE: Journal of Biological Chemistry, VOLUME: 284, ISSUE: 41
AUTHORS: Link, W; Oyarzabal, J; Serelde, BG; Albarran, MI; Rabal, O; Cebria, A; Alfonso, P; Fominaya, J; Renner, O; Peregrina, S; Soilan, D; Ceballos, PA; Hernandez, AI; Lorenzo, M; Pevarello, P; Granda, TG; Kurz, G; Carnero, A; Bischoff, JR;
PUBLISHED: 2009, SOURCE: Journal of Biological Chemistry, VOLUME: 284, ISSUE: 41
60
TITLE: Exploring the biological space of FOXO regulation: discovery of therapeutic targets and small molecule inhibitors for anticancer therapy Full Text
AUTHORS: Link, W;
PUBLISHED: 2009, SOURCE: New Biotechnology, VOLUME: 25
AUTHORS: Link, W;
PUBLISHED: 2009, SOURCE: New Biotechnology, VOLUME: 25
